Signaling pathways governing glioma cancer stem cells behavior

A Nasrolahi, S Azizidoost, K Radoszkiewicz, S Najafi… - Cellular …, 2023 - Elsevier
Glioma is the most common malignant brain tumor that develops in the glial tissue. Several
studies have identified that glioma cancer stem cells (GCSCs) play important roles in tumor …

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and future

ML Hu, YR Pan, YY Yong, Y Liu, L Yu, DL Qin… - Ageing research …, 2023 - Elsevier
Abstract Poly (ADP-ribose) polymerase 1 (PARP1) is a first responder that recognizes DNA
damage and facilitates its repair. Neurodegenerative diseases, characterized by progressive …

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells

A Vanderlinden, CG Jones, KN Myers… - British Journal of …, 2023 - nature.com
Background High-grade gliomas are primary brain cancers with unacceptably low and
persistent survival rates of 10–16 months for WHO grade 4 gliomas over the last 40 years …

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition

Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao… - Journal of Experimental …, 2022 - Springer
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …

Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression

Ż Kałuzińska-Kołat, D Kołat, K Kośla… - Frontiers in …, 2023 - frontiersin.org
Introduction Glioblastoma (GBM) is notorious for its clinical and molecular heterogeneity,
contributing to therapeutic failure and a grim prognosis. WWOX is one of the tumor …

A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy

B Priya, D Chhabria, JM Dhongdi, S Kirubakaran - Bioorganic Chemistry, 2024 - Elsevier
Glioblastoma multiforme (GBM) is an aggressive, incurable brain tumor with poor prognosis
and limited treatment options. Temozolomide (TMZ) is the standard chemotherapeutic …

ERCC1 overexpression increases radioresistance in colorectal cancer cells

YJ Huang, MY Huang, TL Cheng, SH Kuo, CC Ke… - Cancers, 2022 - mdpi.com
Simple Summary The 20–30% of locally advanced rectal cancer patients undergoing
preoperative concurrent chemoradiotherapy had no expected efficacy, and ERCC1 …

[HTML][HTML] Design of Experiments to Tailor the Potential of BSA-Coated Peptide Nanocomplexes for Temozolomide/p53 Gene Co-Delivery

I Afonso, AR Neves, D Eusébio, T Albuquerque… - Pharmaceutics, 2024 - mdpi.com
Background: Gene therapy can be viewed as a promising/valuable therapeutic approach
directed to cancer treatment, including glioblastoma. Concretely, the combination of gene …

New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs

BO Pirlog, S Ilut, R Pirlog, P Chiroi, A Nutu… - Expert Reviews in …, 2023 - cambridge.org
Background Glioblastoma (GBM) is the most frequent type of primary brain cancer, having a
median survival of only 15 months. The current standard of care includes a combination of …

Methylcellulose/agarose hydrogel loaded with short electrospun PLLA/laminin fibers as an injectable scaffold for tissue engineering/3D cell culture model for tumour …

B Niemczyk-Soczynska, D Kolbuk, G Mikulowski… - RSC …, 2023 - pubs.rsc.org
This research aimed at designing and fabricating a smart thermosensitive injectable
methylcellulose/agarose hydrogel system loaded with short electrospun bioactive …